INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
CR

Cohlhepp Ryan

Director, President and COOCIK 0002034665

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 5
Max Insider Score23
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$69K
3,828 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Bicara Therapeutics Inc.Director, President and COO · Nov 25, 2025
0
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M
$30K
8,000 sh
Dec 15, 2025
Dec 16, 2025
traded Dec 15, 2025
+1d
SEC FORM 4

Evidence

9
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$149K
8,000 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC FORM 4

Evidence

9
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$84K
4,500 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC FORM 4

Evidence

0
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
8,000 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC FORM 4

Evidence

0
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$30K
8,000 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC FORM 4

Evidence

23
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$144K
8,000 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC FORM 4

Evidence

23
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$81K
4,500 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC FORM 4

Evidence

3
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
8,000 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC FORM 4

Evidence